ZIM
CLVS

Zacks Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Zacks Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,520
Closed -$99K – 605
2020
Q1 		$99K Buy
+15,520
New +$125K ﹤0.01% 478
2017
Q1 		– Sell
-6,635
Closed -$295K – 751
2016
Q4 		$295K Sell
6,635
-2,663
-29% -$93.7K 0.01% 507
2016
Q3 		$335K Buy
+9,298
New +$199K 0.01% 487

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Zacks Investment Management's CLVS Position: Q2 2020 in Review

Zacks Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 15,520 shares — an estimated $99K sold.

Zacks Investment Management first reported a position in CLVS in Q3 2016 and held it in 3 quarters. The position peaked at $335K in Q3 2016. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Zacks Investment Management reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Zacks Investment Management sold 15,520 Clovis Oncology, Inc. shares in Q2 2020, an estimated $99K.
  • Zacks Investment Management first reported a position in Clovis Oncology, Inc. in Q3 2016 and held it in 3 quarters.
  • Zacks Investment Management's Clovis Oncology, Inc. position peaked at $335K in Q3 2016.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Zacks Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.